Cardiac troponin I (cTnI) and T (cTnT)
Cardiology Network |
Discuss Cardiac troponin I (cTnI) and T (cTnT) further in the WikiDoc Cardiology Network |
Adult Congenital |
---|
Biomarkers |
Cardiac Rehabilitation |
Congestive Heart Failure |
CT Angiography |
Echocardiography |
Electrophysiology |
Cardiology General |
Genetics |
Health Economics |
Hypertension |
Interventional Cardiology |
MRI |
Nuclear Cardiology |
Peripheral Arterial Disease |
Prevention |
Public Policy |
Pulmonary Embolism |
Stable Angina |
Valvular Heart Disease |
Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Cardiac troponin I (cTnI) and T (cTnT) are the current gold standards for detecting myocardial necrosis. Elevation in the setting of NSTE ACS is associated with a markedly increased risk of death and reinfarction. GP IIb/IIIa inhibitors can blunt the magnitude of this troponin release in NSTE ACS. Furthermore, troponin elevation identifies a subset of patients who enjoy the greatest benefit from both GP IIb/IIIa inhibition and early invasive therapy. [1] [2]